Cas:709649-64-9 1-(2,3-Dihydro-1,4-benzodioxin-5-yl)-N-methylmethanamine manufacturer & supplier

Chemical Name:1-(2,3-Dihydro-1,4-benzodioxin-5-yl)-N-methylmethanamine

CAS.NO:709649-64-9

Synonyms:1-(2,3-Dihydro-1,4-benzodioxin-5-yl)-N-methylmethanamine

Molecular Formula:C₁₀H₁₃NO₂

Molecular Weight:179.21600

HS Code:2932999099

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:30.49000

Exact Mass:179.09500

LogP:1.56810

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-(2,3-Dihydro-1,4-benzodioxin-5-yl)-N-methylmethanamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(2,3-Dihydro-1,4-benzodioxin-5-yl)-N-methylmethanamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(2,3-Dihydro-1,4-benzodioxin-5-yl)-N-methylmethanamine Use and application,1-(2,3-Dihydro-1,4-benzodioxin-5-yl)-N-methylmethanamine technical grade,usp/ep/jp grade.

Related News: Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities. 1-(2,3-Dihydro-1,4-benzodioxin-5-yl)-N-methylmethanamine manufacturer We manufacture APIs and drug manufacturers make medicines from APIs. 1-(2,3-Dihydro-1,4-benzodioxin-5-yl)-N-methylmethanamine supplier Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities. 1-(2,3-Dihydro-1,4-benzodioxin-5-yl)-N-methylmethanamine vendor We manufacture APIs and drug manufacturers make medicines from APIs. 1-(2,3-Dihydro-1,4-benzodioxin-5-yl)-N-methylmethanamine factory This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician��s Choice plus Best Supportive Care.